Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

25.74 +0.03 (+0.12%)

Official Closing Price Updated: 5:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Why Novo Nordisk Stock Just Hit a 4-Year Low ↗

Today 19:35 EST

Novo Nordisk's drug trial failure is the latest in a series of 2025 woes for the company.

Via The Motley Fool

Friday's session: most active stock in the S&P500 index ↗

November 28, 2025

Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.

Via Chartmill

8 Dividend Stocks Every Investor Should Consider ↗

November 28, 2025

From high-yield pharma plays to growth-oriented compounders, these eight stocks offer something for every dividend investor.

Via The Motley Fool

Is Pfizer Stock Underperforming the Dow?

November 28, 2025

While Pfizer has lagged behind the broader Dow Jones Industrial Average, Wall Street remains optimistic about the stock.

Via Barchart.com

Topics Intellectual Property Stocks

Roivant (ROIV) Q2 2026 Earnings Call Transcript ↗

November 27, 2025

Roivant (ROIV) Q2 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years ↗

November 27, 2025

These top dividend stocks could intrigue a wide range of investors.

Via The Motley Fool

Topics Intellectual Property

JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗

November 26, 2025

JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season.

Via Stocktwits

Topics Economy Government

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings ↗

November 26, 2025

Valneva's Phase 2 data show strong, lasting immunity for its Pfizer-partnered Lyme vaccine as the company consolidates operations in France.

Via Benzinga

Merck & Co. Stock: Is MRK Outperforming the Healthcare Sector?

November 26, 2025

Merck has outperformed the healthcare sector over the past three months. Moreover, Wall Street analysts are moderately optimistic about its prospects.

Via Barchart.com

Topics ETFs

Did Pfizer Just Say "Checkmate" to Novo Nordisk? ↗

November 26, 2025

The weight loss drug market may approach almost $100 billion by the end of the decade.

Via The Motley Fool

The Data Vacuum: How Delayed Economic Reports Are Clouding Market Stability and Investor Confidence

November 25, 2025

The financial markets are currently navigating a turbulent sea of uncertainty, grappling with the profound implications of significantly delayed economic reports. As of November 25, 2025, the...

Via MarketMinute

Topics Bonds Credit Cards Economy

Is This the Best Value Stock to Buy While Markets Are Volatile? ↗

November 25, 2025

This big pharma stock should be even more appealing to investors amid market turbulence.

Via The Motley Fool

Topics Economy Intellectual Property

Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks. ↗

November 25, 2025

Although the U.S. stock market is trading close to an all-time high, its dividend yield is approaching a 20-year low, and that's creating a challenge for income-oriented investors.

Via The Motley Fool

What's going on in today's session: S&P500 most active stocks ↗

November 24, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Novo Nordisk Shares Plunge as Alzheimer's Drug Trial Fails to Meet Primary Endpoint

November 24, 2025

Copenhagen, Denmark – November 24, 2025 – Novo Nordisk's (CPH: NOVO B) stock experienced a significant and immediate downturn today, plummeting by over 10% in early trading, following the announcement...

Via MarketMinute

2 High-Yield Dividend ETFs to Buy to Generate Passive Income ↗

November 23, 2025

The Schwab U.S. Dividend Equity ETF and Alerian MLP ETF are two nice high-yield ETF options.

Via The Motley Fool

Topics ETFs Retirement Stocks

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗

November 22, 2025

For those with decades left in their investing journey, these top healthcare stocks could be worthy portfolio contenders.

Via The Motley Fool

Topics Intellectual Property

Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut.

Via StockStory

Topics Economy

Why Are Shares of Pfizer Up Today? ↗

November 21, 2025

Pfizer rises after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains.

Via Benzinga

Which S&P500 stocks are the most active on Friday? ↗

November 21, 2025

Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for...

Via Chartmill

Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug ↗

November 21, 2025

Texas sues Sanofi and Bristol-Myers Squibb over alleged Plavix failures, as Paxton also finalizes a $41.5 million settlement with Pfizer and Tris over quality issues in children's medication.

Via Benzinga

Topics Lawsuit

This 7%-Yielding Dividend Stock Is About to Enter an Exciting New Phase ↗

November 21, 2025

The drugmaker may not continue to lag the market for much longer.

Via The Motley Fool

Goldman Sachs Just Delivered Bad News for U.S. Investors ... Sort Of. Here's What You Need to Know. ↗

November 21, 2025

The investment bank's analysts simply recognize how much has changed in just the past few years, and what that means for the near future.

Via The Motley Fool

Topics Artificial Intelligence Economy

AI Unleashes a Healthcare Revolution: Smarter Care, Empowered Providers, Healthier Nation

November 20, 2025

Artificial intelligence is rapidly transforming America's healthcare system, offering immediate and profound benefits across the entire spectrum of care, from individual patients to providers and...

Via TokenRing AI

Topics Artificial Intelligence

Exact Sciences Stock Pops on $21 Billion Deal. Is It Too Late to Buy EXAS Here?

November 20, 2025

Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026.

Via Barchart.com

Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. ↗

November 20, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Is Pfizer's 6.9%-Yielding Dividend Still Safe? ↗

November 20, 2025

The company's earnings fell by 21% last quarter.

Via The Motley Fool

Cincinnati Financial Stock Outlook: Is Wall Street Bullish or Bearish?

November 20, 2025

Although Cincinnati Financial has lagged behind the SPX over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Via Barchart.com

Zoetis (ZTS): Buy, Sell, or Hold Post Q3 Earnings?

November 19, 2025

Zoetis’s stock price has taken a beating over the past six months, shedding 28.6% of its value and falling to a new 52-week low of $116.88 per share. This was partly due to its softer quarterly results...

Via StockStory

Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too?

November 19, 2025

Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end?

Via Barchart.com

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.